AAAAAA
Results:
1-11
|
Results: 11
Authors:
Montero, S
Guzman, C
Vargas, C
Ballestin, C
Cortes-Funes, H
Colomer, R
Citation: S. Montero et al., Prognostic value of cytosolic p53 protein in breast cancer, TUMOR BIOL, 22(5), 2001, pp. 337-344
Authors:
Menendez, JA
Barbacid, MD
Montero, S
Sevilla, E
Escrich, E
Solanas, M
Cortes-Funes, H
Colomer, R
Citation: Ja. Menendez et al., Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells, EUR J CANC, 37(3), 2001, pp. 402-413
Authors:
Colomer, R
Shamon, LA
Tsai, MS
Lupu, R
Citation: R. Colomer et al., Herceptin: From the bench to the clinic, CANCER INV, 19(1), 2001, pp. 49-56
Authors:
Perez-Gracia, JL
Colomer, R
Ruiz-Casado, A
Arcediano, A
Tornamira, MV
Gomez-Martin, C
Valentin, V
Mendiola, C
Cortes-Funes, H
Hornedo, J
Citation: Jl. Perez-gracia et al., High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial, BONE MAR TR, 27(2), 2001, pp. 117-123
Authors:
Perez-Gracia, JL
Colomer, R
Esteban, E
Barcelo, R
Benavides, M
Puertas, J
Arcediano, A
Tornamira, MV
Valentin, V
Munoz, A
Cortes-Funes, H
Hornedo, J
Citation: Jl. Perez-gracia et al., High-Dose Mitoxantrone and Cyclophosphamide Without Stem Cell Support in Patients with High-Risk and Advanced Breast Carcinoma - A Phase II Multicentric Trial, CANCER, 92(10), 2001, pp. 2508-2516
Authors:
Colomer, R
Montero, S
Lluch, A
Ojeda, B
Barnadas, A
Casado, A
Massuti, B
Cortes-Funes, H
Lloveras, B
Citation: R. Colomer et al., Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer, CLIN CANC R, 6(6), 2000, pp. 2356-2362
Authors:
Colomer, R
Llombart, A
Lluch, A
Ojeda, B
Barnadas, A
Caranana, V
Fernandez, Y
De Paz, L
Guillem, V
Alonso, S
Citation: R. Colomer et al., Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial, SEMIN ONCOL, 27(1), 2000, pp. 20-24
Authors:
Lluch, A
Ojeda, B
Colomer, R
Barnadas, A
Massuti, B
Casado, A
Angeles, C
Maroto, P
Citation: A. Lluch et al., Doxorubicin and paclitaxel in advanced breast carcinoma - Importance of prior adjuvant anthracycline therapy, CANCER, 89(11), 2000, pp. 2169-2175
Authors:
Montero, S
Lloveras, B
Cortes-Funes, H
Colomer, R
Citation: S. Montero et al., Correspondence re: S. Shimoyama et al., Increased Serum Angiogenin Concentration in Colorectal Cancer is Correlated with Cancer Progression. Clin. Cancer Res., 5 : 1125-1130, 1999., CLIN CANC R, 5(11), 1999, pp. 3722-3723
Authors:
Lassaletta, L
Brandariz, JA
Benito, A
de la Cruz, J
Gomez, C
Ballestin, C
Hitt, R
Colomer, R
Alvarez-Vicent, JJ
Citation: L. Lassaletta et al., p53 expression in locally advanced pharyngeal squamous cell carcinoma, ARCH OTOLAR, 125(12), 1999, pp. 1356-1359
Authors:
Hidalgo, M
Hornedo, J
Lumbreras, C
Trigo, JM
Colomer, R
Perea, S
Gomez, C
Ruiz, A
Garcia-Carbonero, R
Cortes-Funes, H
Citation: M. Hidalgo et al., Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever - A prospective, randomized clinical trial, CANCER, 85(1), 1999, pp. 213-219
Risultati:
1-11
|